Page 265 - Read Online

Guo et al. Diagnosis and treatment of cryptococcal meningitis

monoclonal antibody-based latex agglutination test for diagnosis in the immunocompromised host. Curr Opin Infect Dis 2008;21:596-603.
of cryptococcosis: comparison with two tests using polyclonal 49. Sloan D, Dlamini S, Paul N, Dedicoat M. Treatment of acute cryptococcal
antibodies. J Clin Microbiol 1992;30:2544-50. meningitis in HIV infected adults, with an emphasis on resource-limited
31. Perfect JR. Fungal diagnosis: how do we do it and can we do better? settings. Cochrane Database Syst Rev 2008;4:CD005647.
Curr Med Res Opin 2013;29 Suppl 4:3-11. 50. Capilla J, Flavia A, Mayayo E, Guarro J. Efficacy of intrathecal
32. Wang LX, Shi LB, Chen WS, Xiao ZH, Cheng D. Detection of liposomal amphotericin B plus oral posaconazole in the treatment of
capsular polysaccharide antigen by latex agglutination test for early acute meningeal cryptococcosis in a murine model. Int J Antimicrob
diagnosis of meningitis or pneumonia caused by Cryptococcus Agents 2013;42:282-3.
neoformans. Jian Yan Yi Xue 2008;23:55-7. 51. Bicanic T, Wood R, Meintjes G, Rebe K, Brouwer A, Loyse A, Bekker
33. Bennett JE, Bailey JW. Control for rheumatoid factor in the latex test LG, Jaffar S, Harrison T. High-dose amphotericin B with flucytosine
for cryptococcosis. Am J Clin Pathol 1971;56:360-5. for the treatment of cryptococcal meningitis in HIV-infected patients:
34. Tanner DC, Weinstein MP, Fedorciw B, Joho KL, Thorpe JJ, Reller L. a randomized trial. Clin Infect Dis 2008;47:123-30.
Comparison of commercial kits for detection of cryptococcal antigen. 52. Kambugu A, Meya DB, Rhein J, O’Brien M, Janoff EN, Ronald AR,
J Clin Microbiol 1994;32:1680-4. Kamya MR, Mayanja-Kizza H, Sande MA, Bohjanen PR, Boulware
35. Gade W, Hinnefeld SW, Babcock LS, Gilligan P, Kelly W, Wait K, Greer DR. Outcomes of cryptococcal meningitis in Uganda before and after
D, Pinilla M, Kaplan RL. Comparison of the PREMIER cryptococcal the availability of highly active antiretroviral therapy. Clin Infect Dis
antigen enzyme immunoassay and the latex agglutination assay for 2008;46:1694-701.
detection of cryptococcal antigens. J Clin Microbiol 1991;29:1616-9. 53. Pappas PG, Chetchotisakd P, Larsen RA, Manosuthi W, Morris
36. Lawn SD, Wood R. Point-of-care urine antigen screening tests for MI, Anekthananon T, Sungkanuparph S, Supparatpinyo K, Nolen
tuberculosis and cryptococcosis: potential for mortality reduction in TL, Zimmer LO, Kendrick AS, Johnson P, Sobel JD, Filler SG.
antiretroviral treatment programs in Africa. Clin Infect Dis 2012;54:739-40. A phase II randomized trial of amphotericin B alone or combined
37. Sanchini A, Smith IM, Sedlacek L, Schwarz R, Tintelnot K, Rickerts with fluconazole in the treatment of HIV-associated cryptococcal
V. Molecular typing of clinical Cryptococcus neoformans isolates meningitis. Clin Infect Dis 2009;48:1775-83.
collected in Germany from 2004 to 2010. Med Microbiol Immunol 54. Miller RP, Bates JH. Amphotericin B toxicity. A follow-up report of
2014;203:333-40. 53 patients. Ann Intern Med 1969;71:1089-95.
38. Sow D, Tine RC, Sylla K, Djiba M, Ndour CT, Dieng T, Ndiaye JL, 55. Catalán M, Montejo JC. Systemic antifungals. Pharmacodynamics and
Faye B, Ndiaye D, Gaye O, Dieng Y. Cryptococcal meningitis in pharmacokinetics. Rev Iberoam Micol 2006;23:39-49. (in Spanish)
Senegal: epidemiology, laboratory findings, therapeutic and outcome of 56. Xu N, Wen H, Chen JH. Recent development of drug therapy in
cases diagnosed from 2004 to 2011. Mycopathologia 2013;176:443-9.
cryptococcal meningitis. Zhongguo Zhen Jun Xue Za Zhi 2006;1:248-52.
39. Yao ZW, Lu X, Shen C, Lin DF. Comparison of flucytosine 57. Brizendine KD, Pappas PG. Cryptococcal meningitis: current
andfluconazole combined with amphotericin B for the treatment of approaches to management in patients with and without AIDS. Curr
HIV-associated cryptococcal meningitis: a systematic review and
meta-analysis. Eur J Clin Microbiol Infect Dis 2014;33:1339-44. Infect Dis Rep 2010;12:299-305.
40. Day JN, Chau TT, Lalloo DG. Combination antifungal therapy for 58. Liliang PC, Liang CL, Chang WN, Lu K, Lu CH. Use of
cryptococcal meningitis. N Engl J Med 2013;368:2522-3. ventriculoperitoneal shunts to treat uncontrollable intracranial
41. Saag MS, Cloud GA, Graybill JR, Sobel JD, Tuazon CU, Johnson hypertension in patients who have cryptococcal meningitis without
PC, Fessel WJ, Moskovitz BL, Wiesinger B, Cosmatos D, Riser L, hydrocephalus. Clin Infect Dis 2002;34:E64-8.
Thomas C, Hafner R, Dismukes WE. A comparison of itraconazole 59. Graybill JR, Sobel J, Saag M, van Der Horst C, Powderly W, Cloud
versus fluconazole as maintenance therapy for AIDS-associated G, Riser L, Hamill R, Dismukes W. Diagnosis and management of
cryptococcal meningitis. National Institute of Allergy and Infectious increased intracranial pressure in patients with AIDS and cryptococcal
Diseases Mycoses Study Group. Clin Infect Dis 1999;28:291-6. meningitis. The NIAID Mycoses Study Group and AIDS Cooperative
42. Gullo FP, Rossi SA, Sardi Jde C, Teodoro VL, Mendes-Giannini MJ, Treatment Groups. Clin Infect Dis 2000;30:47-54.
Fusco-Almeida AM. Cryptococcosis: epidemiology, fungal resistance, 60. Sheldon P, Ommaya AK. Ventricular dilatation masking the presence
and new alternatives for treatment. Eur J Clin Microbiol Infect Dis of cerebral tumors. Acta Radiol Diagn (Stockh) 1963;1:628-37.
2013;32:1377-91. 61. Larsen RA, Pappas PG, Perfect J, Aberg JA, Casadevall A, Cloud GA,
43. Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly James R, Filler S, Dismukes WE. Phase I evaluation of the safety and
WG, Sobel JD, Dismukes WE. Practice guidelines for the management pharmacokinetics of murine-derived anticryptococcal antibody 18B7
of cryptococcal disease. Infectious Diseases Society of America. Clin in subjects with treated cryptococcal meningitis. Antimicrob Agents
Infect Dis 2000;30:710-8. Chemother 2005;49:952-8.
44. Dromer F, Bernede-Bauduin C, Guillemot D, Lortholary O; French 62. Netea MG, Brouwer AE, Hoogendoorn EH, Van der Meer JW,
Cryptococcosis Study Group. Major role for amphotericin B-flucytosine Koolen M, Verweij PE, Kullberg BJ. Two patients with cryptococcal
combination in severe cryptococcosis. PLoS One 2008;3:e2870. meningitis and idiopathic CD4 lymphopenia: defective cytokine
45. Fang W, Fa Z, Liao W. Epidemiology of Cryptococcus and cryptococcosis production and reversal by recombinant interferon- gamma therapy.
in China. Fungal Genet Biol 2015;78:7-15. Clin Infect Dis 2004;39:e83-7.
46. Hodge G, Cohen SH, Thompson GR 3rd. In vitro interactions 63. Jarvis JN, Meintjes G, Rebe K, Williams GN, Bicanic T, Williams A,
between amphotericin B and hydrocortisone: potential implications Schutz C, Bekker LG, Wood R, Harrison TS. Adjunctive interferon-γ
for intrathecal therapy. Med Mycol 2015;53:749-53. immunotherapy for the treatment of HIV-associated cryptococcal
47. Gazzoni AF, Capilla J, Mayayo E, Guarro J. Efficacy of intrathecal meningitis: a randomized controlled trial. AIDS 2012;26:1105-13.
administration of liposomal amphotericin B combined with 64. Bryan RA, Jiang Z, Howell RC, Morgenstern A, Bruchertseifer F,
voriconazole in amurine model of cryptococcal meningitis. Int J Casadevall A, Dadachova E. Radioimmunotherapy is more effective
Antimicrob Agents 2012;39:223-7. than antifungal treatment in experimental cryptococcal infection. J
48. Jarvis JN, Dromer F, Harrison TS, Lortholary O. Managing cryptococcosis Infect Dis 2010;202:633-7.

256 Neuroimmunology and Neuroinflammation ¦ Volume 3 ¦ November 18, 2016